Stay updated on IMGN779 in CD33+ AML: Clinical Trial
Sign up to get notified when there's something new on the IMGN779 in CD33+ AML: Clinical Trial page.

Latest updates to the IMGN779 in CD33+ AML: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedLocations section reorganized: a unified 'Locations' section was added and state-specific location headings were removed. The revision updated from v3.3.2 to v3.3.3.SummaryDifference0.8%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check56 days agoChange DetectedThe government funding lapse notice about updates and operating status has been removed from the page. The rest of the study details (title, conditions, design, locations, and outcome measures) remain unchanged.SummaryDifference0.4%

- Check78 days agoChange DetectedNo significant changes detected on the Study Details page; the core information and page structure remain consistent with the prior version.SummaryDifference0.4%

- Check99 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.SummaryDifference6%

- Check106 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

Stay in the know with updates to IMGN779 in CD33+ AML: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMGN779 in CD33+ AML: Clinical Trial page.